You probably remember how last winter's flu felt heavier than usual. Many people got sick even after their shot, and news reports kept mentioning a new variant spreading fast.
This year's vaccine was built with that experience in mind.
All three virus components in the 2026-2027 flu vaccine have been updated, according to the CDC. The biggest change targets an H3N2 subvariant called subclade K that spread widely during the 2025-2026 season.
Subclade K was first identified in June 2025, months after the previous season's vaccine strains were already locked in. By mid-February 2026, CDC genetic analysis showed that 83 percent of H3N2 viruses sampled in the United States belonged to this subvariant.
Also read: Six-month study links daily supplement to lower blood pressure and reduced arterial stiffness
Why the formula update matters this time
The mismatch had a real cost. An interim report in the CDC's MMWR on 2025-2026 vaccine effectiveness showed only modest protection against the drifted H3N2 subclade K viruses that dominated the season.
Reformulating the shot does not guarantee a perfect match this time either. Flu viruses keep evolving through the winter. But the new vaccine was designed with subclade K specifically in mind, which was not true of last year's shot.
Egg-free doses expand to more than a quarter of the supply
For the 2026-2027 season, 27 percent of the US flu vaccine supply will be produced without eggs. That works out to about 36 million of a projected 135 million doses.
The CDC has guided since the 2023-2024 season that people with egg allergy can get any flu vaccine appropriate for their age and health status. More non-egg doses on shelves simply means that choice is now easier to find at a local pharmacy.
Also read: Early warning signs of shingles that appear days before the rash
When to get vaccinated and who should go first?
The CDC recommends being vaccinated ideally by the end of October. Vaccination continues to help as flu viruses circulate through the winter, so missing that target is not a reason to skip the shot.
People at higher risk of serious flu complications are encouraged to go first.
That group includes adults aged 65 and older, children aged 6 months through 4 years, pregnant people, and anyone living with chronic conditions such as heart disease, lung disease, or diabetes.
All 2026-2027 flu vaccines are approved for people aged 6 months and older. Nearly all of the supply, 99 percent, is free of the preservative thimerosal, and the full supply is trivalent, meaning each shot targets three virus components.
Also read: FDA recalls blood pressure medication from two batches: Check if yours is affected
Updated flu vaccines are available now at pharmacies, clinics, and doctors' offices across the country.
Also read: The colors on your plate may line up with a 7 percent lower risk of early death
This article is made and published by Ida-Marie Palm Varbæk, who may have used AI in the preparation.